Entries by Ryan Bledsoe

Fziomed Initiates Commercialization of Oxiplex Gel in the United States

/in /by

Best-in-class, synthetic, absorbable gel for use as an adjunct in lumbar spine surgery for the reduction of leg pain and neurological symptoms now available in the United States. SAN LUIS OBISPO, California, Nov. 5, 2025 — Fziomed, Inc. (“Fziomed” or the “Company”), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable […]

Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery

/in /by

Oxiplex is the only FDA authorized intraoperative gel indicated as an adjunct to lumbar spinal surgery to reduce postoperative leg pain and neurological symptoms. Oxiplex gel has the potential to become a new standard of care as an adjunctive therapy. SAN LUIS OBISPO, California, July 8, 2025 — Fziomed, Inc. (“Fziomed” or the “Company”), a […]

Fziomed, Inc.
231 Bonetti Drive
San Luis Obispo, CA 93401
USA
Phone: +1 (805) 546-0610
Fax: +1 (805) 546-0571
Email: [email protected]

The following trademarks are owned by Fziomed, Inc. and registered in the United States and certain foreign jurisdictions: FZIOMED®, OXIPLEX®, OXIPLEX/SP®, DYNAVISC®, INTERPOSE®, INTERCOAT®, OXIPLEX/AP®, and OXIPLEX/IU®.

Website design RainCastle Communications.

© 2025 Fziomed, Inc.
All rights reserved.

Privacy Policy

Last update: Feb. 25, 2025

Quicklinks

  • Go to USA Site
  • Contact